News

Why Corcept Therapeutics’ Relacorilant Fell Short And What It Means For The Company

This article was written byFollowBioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible,

News

Editor's Top Picks

Goldman Sachs Emerging Markets Equity Insights Fund Q3 2025 Commentary

Market Review In the third quarter of 2025, the MSCI Emerging Markets Index rose by 10.64%, contributing to the strongest

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

Companies rethink consultants as they fret about economic outlook

Uncertainty in the global economy threatens a year of upheaval in the US consulting industry,

Taiwan Semiconductor Offers Excellent Entry Point (NYSE:TSM)

In this article, I will outline why I think Taiwan Semiconductor Manufacturing (NYSE:TSM) offers investors

EU offers Tunisia over €1bn to stem migration

The EU has offered Tunisia more than €1bn in a bid to help the North

Haleon Stock: A Hidden Gem In The Consumer Health Market (NYSE:HLN)

Investment Thesis Haleon (NYSE:HLN) was spun off from GSK (GSK) in July last year and

French schools retain dominance in Masters in Finance teaching

Léon Laulusa has had some welcome news as he starts his new role as dean

CLOI: An Incredible Sturdy Way To Navigate 2023, 6.4% Yield (NYSEARCA:CLOI)

Thesis 2023 has been a fairly bizarre year. Entering, all large bank analysts were screaming

Andreessen Horowitz to open London crypto office in first push overseas

Andreessen Horowitz has chosen London for its first office outside the US, betting that the

BCV: An Opportunity In The Convertible Securities Space (NYSE:BCV)

Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members

AI ‘euphoria’ and EV bets drive South Korea market rally

South Korea’s $1.8tn stock market is approaching bull market territory, as foreign investors pile into

Palantir Technologies: Sell The AI Rip (NYSE:PLTR)

After a solid beat on Q1'23 earnings, Palantir Technologies (NYSE:PLTR) has soared in what wasn't

Odey EU funds discuss restrictions on withdrawals as founder sidelined

EU funds managed by Odey Asset Management are discussing restrictions on investors’ withdrawals as part

Medical Properties Trust Reveals Its Own Bullish Case (NYSE:MPW)

As a rather outspoken person myself, it's refreshing to see a management team actively relate

Live news: The week ahead

A defiant Donald Trump will once again be in the spotlight when he appears at

Adobe Stock: Buy The Bullish Momentum (Technical Analysis) (NASDAQ:ADBE)

In an era rapidly advancing towards an AI-driven future, numerous companies are tactically aligning their

UBS sets ‘red lines’ for Credit Suisse staff after takeover completion

UBS is to impose tight restrictions on Credit Suisse bankers including a ban on new